Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2008
11/20/2008US20080287344 Use of Amino Acids for Making Medicines for Treating Insulin Resistance
11/20/2008CA2686885A1 Composition for maintaining androgen and androgen-like uptake potential by cells
11/19/2008EP1992641A2 GLP-1 analogues
11/19/2008EP1992335A1 Spray drying methods and compositions thereof
11/19/2008EP1991559A2 Oxa-steroids derivatives as selective progesterone receptor modulators
11/19/2008EP1991549A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
11/19/2008EP1991523A1 Selective androgen receptor modulators
11/19/2008EP1991223A1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
11/19/2008EP1805201B1 15beta-SUBSTITUTED STEROIDS HAVING SELECTIVE ESTROGENIC ACTIVITY
11/19/2008EP1453539B1 Immunotherapeutic methods and systems
11/19/2008EP1268775B1 The high bone mass gene of 11q13.3
11/19/2008CN101309704A Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
11/19/2008CN101306000A Testosterone generating and metabolizing enhancer
11/18/2008US7452983 Protein which binds to Akt2
11/18/2008US7452883 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2395481C Hormone receptor modulation
11/18/2008CA2359640C Topical sprays
11/18/2008CA2352430C New pharmaceutical composition and the process for its preparation
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008135291A1 New progesterone receptor modulators
11/13/2008WO2008115069A3 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents
11/13/2008US20080281092 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
11/13/2008US20080279969 Composition Comprising Bamboo Extract for Androgen Agonist
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008CA2684088A1 New progesterone receptor modulators
11/12/2008EP1990061A2 Pharmaceutical composition for transdermal or transmucosal delivery
11/12/2008EP1989218A2 17-phosphorous steroid derivatives useful as progesterone receptor modulators
11/12/2008EP1989217A2 11-phosphorous steroid derivatives useful as progesterone receptor modulators
11/12/2008EP1594545B1 Pharmaceutical composition for transdermal or transmucosal administration
11/12/2008CN101305009A Aza-substituted spiro derivative
11/12/2008CN101304999A Non-steroidal compounds useful as glucocorticoid receptor modulators
11/12/2008CN101304979A Quinazoline derivative and pharmaceutical
11/12/2008CN101301413A Cordyceps sinensis and Rhodiola rosea capsules and preparation thereof
11/12/2008CN101301294A Combinated inhibitors of FBP-ase and antidiabetic agents for diabetes treatment
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449489 e.g. isopropyl [({2-[5-[2-(2-azabicyclo[2.2.2]oct-2-yl)- 1,1-dimethyl-2-oxoethyl]-2-(3,5-dimethylphenyl)-1H-indol-3-yl]propyl }amino)(3-pyridin-4-ylpyrrolidin-1-yl)methylene]carbamate; gonadotrophin releasing hormone antagonists; anticarcinogenic agent; breast, prostate, uretus cancer
11/11/2008US7449455 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol; contraception; melanoma; capable of inhibiting bone loss while showing little or no uterine stimulation, decrease the weight gain, decrease cholesterol levels, prevent bone loss
11/11/2008US7448379 Composition, vessel, dry powder inhalation system, and related methods for transpulmonary administration
11/06/2008WO2008133128A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008133127A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008132153A1 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
11/06/2008WO2008131972A1 Arylmethylen substituted n-acyl-gamma-aminoalcohols
11/06/2008WO2008112498A3 Synthesis and characterization of polymorph form ii of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile
11/06/2008US20080275120 Leucine rich composition
11/06/2008US20080275012 Mixture of androgen, such as testosterone, macrocyclic ketone enhancer and thickener; therapy for glandular disorders
11/06/2008US20080274213 Inhibits reduction in blood testosterone level; extracts of genus Codonopsis; no side effects
11/06/2008US20080274075 PEG-derived cyanoacetamides and PEG-derived phosphonium salts undergo smooth reaction with protein-derived aldehydes or ketones in water under basic reaction conditions; can usually not be cleared by renal filtration, and thus have prolonged half-lives in plasma
11/06/2008CA2685428A1 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
11/06/2008CA2682519A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008CA2682400A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/05/2008EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity
11/05/2008EP1988098A1 Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors
11/05/2008EP1987006A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1986653A1 The treatment of ocular conditions and the systemic side-effects of glucocorticoids
11/05/2008EP1732921B1 Thioamide derivatives as progesterone receptor modulators
11/05/2008EP1605924B1 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008EP0912601B2 Suppression of immune response via inhibition of cathepsin s
11/05/2008CN101300265A Nitrooxy derivatives of glucocorticoids
11/05/2008CN101300000A Equol level regulator
11/05/2008CN101298440A Pharmaceutical salts of reboxetine
11/05/2008CN100430051C Pharmaceutical formulation comprising levothyroxine sodium
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7446108 Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
11/04/2008US7446097 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
10/2008
10/30/2008WO2008129994A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/30/2008WO2008129396A2 Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding
10/30/2008WO2008129303A2 Sustained release
10/30/2008WO2008128791A2 Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen
10/30/2008WO2008064202A3 Modified-release formulations of calcium receptor-active compounds
10/30/2008US20080269307 Quantity of acetyl L-carnitine to be administered is 0.1 to 2 g/day, while the dose of biotin is 1 to 8 mg/day
10/30/2008US20080269139 FGF-5 Supported and Binding Peptides
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080268065 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267925 Recovering beta-islet cells from pancreas of rabbits comprising: harvesting pancreas from newborn rabbits, placing in salt solution, mincing, removing destroyed cells, propagating beta-islet cells, transplant into mammal; treating pancreatic disorder; tissue engineering and repair; regenerative medicine
10/30/2008CA2684453A1 Medicaments and methods to treat autoimmune disease and cancer
10/30/2008CA2684450A1 Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding
10/30/2008CA2683809A1 Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen
10/30/2008CA2681181A1 Sustained release
10/30/2008CA2680769A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/30/2008CA2659603A1 Oil producing microbes and methods of modification thereof
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985612A1 Arymethylen substituted N-Acyl-gamma-aminoalcohols
10/29/2008EP1984343A2 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
10/29/2008EP1983999A2 Regimens for treatment of conditions related to estrogen deficiency
10/29/2008EP1891038B1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
10/29/2008EP1863795B1 Substituted triazole derivatives as oxytocin antagonists
10/29/2008EP1812417B1 Novel 2h-chromene derivatives as selective estrogen receptor modulators
10/29/2008EP1809602B1 Indole derivatives useful as progesterone receptor modulators
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 290